BIOA

Bioage Labs
$8.65
−$0.52 (−5.67%)Sep 10, 2026
2.3FairMoatMint rating

MoatMint rates Bioage Labs (BIOA) 2.3 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 1.2 out of 10.

Key metrics

The numbers that frame BIOA today
Market cap
$397.01M
P/E (TTM)
-4.2
EV / FCF
-3.7
Gross margin
100%
EV / Sales
31.5
ROIC
-61.3%
Div yield
0%
Debt / equity
0.0
52wk Low
$4.68
52wk High
$25.96

BIOA stock rating

How BIOA scores on quality, value, growth, momentum and financial health
2.3out of 10
Fair overallFair business, expensive price
Quality1.2
Growth8.4
Momentum5.5
Value1.2
Financial Health1.5

Growth

Revenue and earnings trend for BIOA
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about BIOA
Is Bioage Labs a good buy?
No. Bioage Labs has poor quality and mixed momentum. The setup is weak overall. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Bioage Labs is selling at a very high price.
What is the market capitalization of BIOA?
Bioage Labs's market capitalization is $397.01M.
What is the P/E ratio for BIOA stock?
Bioage Labs's current P/E ratio is -4.2.
What is the 52-week high for BIOA stock?
The 52-week high for Bioage Labs is $25.96. The current close of $8.65 is 66.7% below that high.
What is the 52-week low for BIOA stock?
The 52-week low for Bioage Labs is $4.68. The current close of $8.65 is 84.8% above that low.
Does BIOA stock pay dividends?
Bioage Labs does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BIOA?
Bioage Labs's Debt / Equity ratio is 0.01.